z-logo
open-access-imgOpen Access
<p>Emerging Role of Immunotherapy for Colorectal Cancer with Liver Metastasis</p>
Author(s) -
Xianzhe Yu,
Lingling Zhu,
Jiewei Liu,
Ming Xie,
Jiang H Chen,
Jianguo Li
Publication year - 2020
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s271955
Subject(s) - colorectal cancer , medicine , metastasis , oncology , immunotherapy , cancer research , gastroenterology , cancer
Colorectal cancer (CRC) is the third most common malignant tumor in the world and the second leading cause of cancer-related deaths, with the liver as the most common site of distant metastasis. The prognosis of CRC with liver metastasis is poor, and most patients cannot undergo surgery. In addition, conventional antitumor approaches such as chemotherapy, radiotherapy, targeted therapy, and surgery result in unsatisfactory outcomes. In recent years, immunotherapy has shown good prospects in the treatment of assorted tumors by enhancing the host's antitumor immune function, and it may become a new effective treatment for liver metastasis of CRC. However, challenges remain in applying immunotherapy to CRC with liver metastasis. This review examines how the microenvironment and immunosuppressive landscape of the liver favor tumor progression. It also highlights the latest research advances in immunotherapy for colorectal liver metastasis and identifies immunotherapy as a treatment regimen with a promising future in clinical applications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here